Financial, market and economic news

WuXi Biologics CEO expects approval for Covid-19 antibody treatment ‘late this year or early next year’

WuXi Biologics has signed more than 10 deals with clients to research antibodies that can potentially deliver treatment for the coronavirus.

Read More

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. AcceptRead More

Privacy & Cookies Policy